Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Protalix Biotherapeutics (PLX)  
$0.26 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 45,560,000
Market Cap: 12.06(M)
Last Volume: 1,167,076 Avg Vol: 555,803
52 Week Range: $0.2646 - $0.2646
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Protalix BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Co.'s proprietary ProCellEx platform is being used to manufacture its marketed product, Elelyso®, for the treatment of Gaucher disease. Co. is also developing, via ProCellEx, a pipeline of products. Co.'s clinical development program for pegunigalsidase alfa, or PRX-102, for the potential treatment of Fabry disease. In addition, Co. is developing uricase, or PRX-115, for the treatment of refractory gout.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 64,516 64,516 242,516
Total Buy Value $0 $90,484 $90,484 $348,299
Total People Bought 0 1 1 2
Total Buy Transactions 0 1 1 3
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 29
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bashan Dror PRESIDENT AND CEO   •       •      –    2023-10-19 4 B $1.40 $90,484 D/D 64,516 132,516 0.01     -
   Bashan Dror President and CEO   •       •      –    2023-08-15 4 A $0.00 $0 I/I 800,000 1,885,458     -
   Naos Yaron Sr. VP, Operations   •       –      –    2023-08-15 4 A $0.00 $0 I/I 187,344 200,817     -
   Rubin Eyal Sr. VP and CFO   •       –      –    2023-08-15 4 A $0.00 $0 I/I 201,903 570,000     -
   Hayon Yael VP, Research & Development   •       –      –    2023-08-15 4 A $0.00 $0 I/I 35,115 35,115     -
   Schwartz Aharon Director   –       •      –    2023-01-03 4 B $1.42 $155,815 D/D 110,000 174,000 2.39     -
   Bashan Dror President and CEO   •       •      –    2022-04-11 4 B $1.50 $102,000 D/D 68,000 68,000 2.81     -
   Rubin Eyal Sr. VP and CFO   •       –      –    2022-02-25 4 A $0.00 $0 I/I 121,951 368,097     -
   Bashan Dror President and CEO   •       •      –    2022-02-25 4 A $0.00 $0 I/I 637,531 1,085,458     -
   Oren Dan 10% Owner   –       –       •   2021-06-03 4 S $2.25 $1,932,304 D/D (857,506) 3,637,314     -
   Oren Dan 10% Owner   –       –       •   2021-06-02 4 S $2.56 $156,553 D/D (61,211) 4,494,820     -
   Oren Dan 10% Owner   –       –       •   2021-02-12 3 IO $0.00 $0 D/D 0 4,556,031     -
   Bashan Dror President and CEO   •       •      –    2020-08-11 4 A $0.00 $0 I/I 447,927 447,927     -
   Rubin Eyal Sr. VP and CFO   •       –      –    2020-08-11 4 A $0.00 $0 I/I 246,146 246,146     -
   Schwartz Aharon Director   –       •      –    2020-04-07 4 B $2.43 $155,264 D/D 64,000 64,000 2.39     -
   Boudes Pol F Director   –       •      –    2020-01-01 3 IO $0.00 $0 D/D 0 40     -
   Manor Moshe President & CEO   •       •      –    2017-05-16 4 B $0.81 $40,500 D/D 50,000 50,000 2.81     -
   Camber Capital Management Llc 10% Owner   •       •       •   2016-12-02 4 S $0.32 $792,000 I/I (2,500,000) 10,775,000     -
   Shaaltiel Yoseph Executive VP, R&D   •       –      –    2016-09-15 4 OE $0.00 $122 D/D 122,162 585,916     -
   Yossi Maimon Vice President & CFO   •       –      –    2015-12-14 4 B $0.78 $7,800 D/D 10,000 10,000 2.74     -
   Camber Capital Management Llc 10% Owner   –       –       •   2015-10-19 4 B $1.00 $4,000,436 I/I 4,000,423 13,275,000 1.5     -
   Camber Capital Management Llc 10% Owner   –       –       •   2015-10-15 3 IO $0.00 $0 I/I 0 9,274,577     -
   Bronfeld Zeev Director   –       •      –    2014-10-02 4 A $0.00 $0 D/D 324,372 2,162,481     -
   Bronfeld Zeev Director   –       •      –    2014-10-02 4 D $0.00 $0 I/I (1,509,948) 0     -
   Bio-Cell Ltd 10% Owner   –       –       •   2014-09-16 4 D $0.00 $0 I/I (8,556,371) 1,509,948     -

  29 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed